MAU DATANG !!!! ???
get ready, buckle up your seat belt....

Icon8888 master level leh.... wau.... you also join in. we are must huat liao !

time to run again, everyone expecting to see very good qtr report

me too waiting, tomorrow Q to buy at 0.40

I chosen to buy then watch :) kikiki

someone playing the fool, continuously key in/selling few shares each time

HUAT!!!

siapatu tengah main-main 6,8,6,8....

Really?

http://www.theedgemarkets.com/my/article/tong%E2%80%99s-momentum-portfolio-feb-10-2015

Tong’s Momentum Portfolio - Feb 10, 2015
By InsiderAsia / InsiderAsia | February 10, 2015 : 11:10 AM MYT

As picked by our momentum algorithm (www.theedgemarkets.com), I bought 22,700 shares of HOVID ( Financial Dashboard) at 44 sen per share

http://www.theedgemarkets.com/my/article/stocks-momentum-hovid

HOVID (Fundamental: 2.1/3; Valuation: 0.6/3) saw its share price rise 1.5 sen or 3.57% to 43.5 sen on substantially higher volume.

Ipoh-based Hovid is a major manufacturer of generic drugs. It derives half of its USD-denominated sales from export, particularly to Asia and Africa and as such, will benefit from the ringgit’s depreciation.

Since disposing its loss-making biodiesel subsidiary Carotech in 2011, Hovid saw its net profit grow at a 2-year CAGR of 7.4% to RM18.1 million in FYJune2014, on the back of revenue of RM183.5 million. A new plant to be completed this year will alleviate capacity constraints and drive future growth.

Hovid has net cash of RM14.5 million or 1.9 sen per share, with ROE of 12.9%. The stock trades at a trailing 12-month P/E of 16.7 times and 1.97 times book. Dividends totalled 1 sen in FY2014, with a yield of 2.4%.

em... plan to start taking tocovid, since confident in HOVID

At least hold until see the qtr report.
Also think of its business, exports earning usd, new factory, new warehouse, handful of Orders, still cents compare to competitors(pharma, kotra, yapsiah, etc)

ok, Q at 0.18

I still hold

still have to wait... sien....

ShinRenNeo, you have any insider news or strong data to back up the fact the after CNY vsolar will explode?

Target 0.460-0.475, S1 0.425, S2 0.370(or Exit/SLoss)

http://klse.i3investor.com/blogs/rhb/70096.jsp

Hovid may trend higher after surpassing the MYR0.425 level in its latest session. Traders may buy as a bullish bias could be present above this level, with a target price of MYR0.475, followed by MYR0.50. The stock may pull back and drift lower if it cannot hold above the MYR0.425 level. In this scenario, support is anticipated at MYR0.37, where traders can exit upon a breach.

sudah datang

mflee9595, you really want other ppl to tell you what price to buy?

singinvestor, you already huat cai loh....congrats

http://www.investalks.com/forum/forum.php?mod=attachment&aid=MTE1NTYyfDZmOWMyMzQ5fDE0MjM0NjgyODd8MTgwMzZ8MTM3NTA%3D&noupdate=yes

mwong3, keep it up, share with us more abt HOVID :)

very well done mwong3.. thank you

Resistance is at rm0.48 followed by rm0.53. Support is at rm0.370.

Malaysia’s largest exported of generic drugs, has been increasing its manufacturing capacity to keep up with export demand after venturing into new markets in African and the Middle East. With a presence in nearly 50 countries, the group’s export driven strategy capitalizes on the rising healthcare expenditure in developing countries.

Hovid is aggressively ramping up its export driven strategy to grow its revenue base.

Currently (Dec 2014), exports stands at 52.5% of revenue.

Another continuing theme for the company is the patent cliff phenomenon. Many of the world’s top selling innovator drugs, which constituted as much as USD34 billion in sales in 2012, will go off patent in the next few years from 2014.

The impending expiration of these patents will then pave the way for generic drugmakers such as Hovid to manufacture cheaper variants, which have a ready market among the developing as well as third world countries. During FY2013, the group added 19 new products to its pipeline, which include eight new ethical drugs for prescription purposes.

Hovid does have a boost from the government in capitalizing on the patent cliff. The enhancement of generic drug manufacturing capacity is one of the EPP under the Pemandu ETP.

It is worth nothing that Pemandu had accorded EPP status on Hovid’s agreement with a subsidiary of global pharmaceutical giant Sanofi-Aventis SA Pty Ltd to develop new generic drugs in 2011.

The company is positioned to take advantage of the rising demand for generic products as numerous patents expire in the next five years from 2014.

On the other hand, apart from creating new generic variants of innovator drugs via R&D, Hovid currently (Dec 2014) has an extensive backlog of existing drugs that are awaiting regulatory approval in numerous countries which should come in by end of 2014.

The drugs estimated at 363 types, are currently (Dec 2014) pending product registrations. These drugs are expected to generate rm30 million in sales within 18 months of being officially registered in the respective countries.

Domestically, while originator drug sales currently (Dec 2014) account for half of total drug sales in Malaysia, the increasing shift towards generic drugs may happen in the near future due to escalating costs.

This shift could spur Hovid’s drug sales domestically. In FY2013, 47.5% of Hovid’s revenue came from domestic sales.

It is said to be a healthcare proxy compared with private hospital operators.

It is liked for its exposure to the export markets which an even bigger growth potential than Malaysia.

no doubt, it's funds collecting, so many huge big lots

pennant chart works! now immediate resistance raised up to 0.440
http://klse.i3investor.com/blogs/KLSETA/69976.jsp

Hovid after breakaway from reversal head and shoulder, it was consolidated for 3 days and formed a pennat, this pennant pattern is typical bullish accumulation for the next move and breakaway from immediate resistance RM0.424 to 0.440/0.465/0.480

Posted by duitKWSPkita > Feb 5, 2015 02:48 PM | Report Abuse X

thanks for ur support Mr. ppginvest.

every time you masuk duit for HOVID, no need tunggu gaji and beli till duit habis this time. HOVID will starts to give you money after next week........ Do not tambah anymore until you see BIG VOLUME to break RM0.480. AFter RM0.480 it is nt hard to challenge the next target at RM0.530.

waitttttttttttttttt. just support no need to top up.
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
Dear duitKWSPkita, thank you for the 6.75% dividend :)
Today I cannot tahan, got the salary, tambah lagi at 0.42...

Manage to sapu 0.420 just now, kikiki...

great!

At 0.420 level fighting between buyers/sellers just now, so far buyers winning (by eating all the sellers shares). Same goes to the WB (0.265)

Let see if the power of pennant able to form up and break up new highest. Many confident shareholders willing to buy more if drop, I am one of them too.

yes, still OK 0.420

breaking 0.150 now!!

Target price of MYR0.16 by next week, followed by MYR0.18

come on baby...

that's for sure, always do that during festival, and already doing it some donations in monthly basis too

OK, salary comes only in 2 weeks time before CNY, wish that time price still at the cheap range

duitKWSPkita ppginvest......... preferably it sustain at 0.425 for certain days rather than pick up aggressively. wat do u think?
05/02/2015 23:10

Jan30 Friday, push at 0.400-0.410 (24.5mil vol, RM9.9Mil transacted)
Feb04 Wed, push at 0.415-0.425 (12.3mil vol, RM5.1Mil transacted)
Feb05 Thur, push at 0.420-0.425 (12.4mil vol, RM4.8Mil transacted)
Feb06 T'ROW, push at 0.4??-0.4?? (VOL ? VAL ?), expects to Q'buy at 0.415/0.410 (but no $$$)

perhaps like duitKWPSkita said/expected to see... it's sideway trend at 0.425-0.430

Tomorrow high chances of HOVID breaks and stays above 0.425?

http://www.thestar.com.my/Business/Business-News/2015/02/05/Support-Line/?style=biz

HOVID scaled to a four-month high of 42.5 sen during intra-day session. Apparently, all the short-term indicators are painting a pretty promising landscape, implying more advances in the short term, targeting the 48-sen barrier or a re-test of the all-time peak of 53 sen. Important support is pegged at the 37-sen level.

eh, pisangkuat, we meet again at here after the bloody hell LBALUM....
this time let us be very good luck at this one, cheers.

Vsolar may rebound further after surpassing the 50-day MAV line and MYR0.135 level. Traders may buy as a bullish bias could be present above this level, with a target price of MYR0.16, followed by MYR0.18. The stock may drift sideways if it cannot hold above the MYR0.135 level. In this scenario, support is anticipated at MYR0.115, where traders can exit upon a breach.

F4 Zai Zai
KUALA LUMPUR: The Employees Provident Fund (EPF) is expected to sustain its high payout ratio by declaring a higher dividend payout for 2014 compared with 6.35% for 2013 and 6.15% for 2012. The source said the dividend rate for 2014 is likely to range between 6.4% and 6.7%.

saya beli sampai duit habis.... kena tunggu gaji sampai dulu

angpao, angpao... meaning you guys plan to sell?
me not interested on this kind of angpao, me feel more excited to see HOVID RM1.00~2.00 at the end of this year, wakakakaka....

itu Angel0l tanya HOW.... HOW in hokkien is crying mah....

how=cry... wuwuwuwuw....

son also loaded more at 0.260, die die lah

ok, loaded more at 415, I bear the risk